BioCardia (BCDA) EBT Margin Growth (1y) (2012 - 2024)
Powered by 
Analysis
BioCardia (BCDA) EBT Margin Growth (1y) (2012 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 672.00 |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 2.23 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 13,390.00 |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 6,324.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | -64,750.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -2.31 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 314,854.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -2,558.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 371.00 |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -4.69 Mn |
| Mar 31, 2024 | 134,801.00 |
| Dec 31, 2023 | -1.32 Mn |
| Sep 30, 2023 | 71,567.00 |
| Jun 30, 2023 | -777,164.00 |
| Mar 31, 2023 | 6,062.00 |
| Dec 31, 2022 | 153,258.00 |
| Sep 30, 2022 | -111,380.00 |
| Jun 30, 2022 | 479,736.00 |
| Mar 31, 2022 | 91,587.00 |
| Dec 31, 2021 | 322,243.00 |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | 817,601.00 |
| Mar 31, 2021 | 566,808.00 |
| Dec 31, 2020 | -595,799.00 |
| Sep 30, 2020 | -959,651.00 |
| Jun 30, 2020 | -885,521.00 |
| Mar 31, 2020 | -1.04 Mn |
| Dec 31, 2019 | 190,921.00 |
| Sep 30, 2019 | 252,887.00 |